Skip to main content

Table 3 Demographic characteristics of subjects enrolled in the study

From: Laboratory monitoring of rivaroxaban in Chinese patients with deep venous thrombosis: a preliminary study

 15 mg BID
(n = 3)
10 mg BID
(n = 9)
20 mg QD
(n = 8)
15 mg QD
(n = 7)
10 mg QD (n = 12)Total (n = 39)P
Demographic characteristicsAge50.0 ± 3.056.4 ± 13.349.1 ± 17.660.9 ± 10.563.4 ± 14.656.9 ± 14.80.147
BMI (kg/m2)26.1 ± 2.323.7 ± 2.523.2 ± 3.826.6 ± 4.422.9 ± 2.423.9 ± 3.30.126
CrCl (mL•min−1)110.4 ± 31.5100.6 ± 27.591.9 ± 35.184.4 ± 20.176.6 ± 34.289.6 ± 31.50.334
ALT (U•L−1)18.7 ± 3.517.0 ± 8.230.4 ± 12.823.8 ± 16.418.7 ± 12.122.1 ± 12.50.092
Alb (g•L−1)43.7 ± 6.739.9 ± 5.142.2 ± 6.439.7 ± 5.941.8 ± 4.041.3 ± 5.20.694